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Structure of a Cannabinoid Receptor Subtype 2 Homodimer Determined
by Cysteine and Homobifunctional Crosslinking Experiments Combined
with Computational Studies
Jagjeet Singh1, Zhao-Hui Song2, Patricia H. Reggio1.
1Department of Chemistry and Biochemistry, University of North Carolina
at Greensboro, Greensboro, NC, USA, 2Department of Pharmacology and
Toxicology, University of Louisville School of Medicine, Louisville, KY, USA.
The cannabinoid CB2 receptor is a Class A GPCR that is highly expressed in the
immune system (Galiegue et al., 1995) and couples via Gi proteins (Glass and
Northup, 1999). In a project to determine the stoichiometry of the CB2/ Gi pro-
tein complex, we first performed crosslinking experiments using a homobifunc-
tional Lys-Lys linker, disuccinimidyl suberate combined with MS/MS analysis.
We identified the following crosslinks: (1) Gi: K349 / CB2: K6.35(245) and (2)
Gi: K317 / CB2: K5.64 (215). Using HgCl2 (and verified via MS/MS analysis),
we also founddisulfidebridge formation betweenGi:C351 /CB2:C3.53(134).A
computer model of the CB2/G-protein complex was constructed using our CB2
inactive (R) and active (R*) statemodels (Hurst et al., 2010), alongwith the crys-
tal structure of Gai1b1g2 (Wall et al., 1995). Our modelling revealed that
achieving all three crosslinks at the same time would require CB2 to be in
a homodimeric form, with one monomer in the inactive state, while the second
monomer is in the activated state, coupled to G protein. This arrangement is con-
sistent with the homodimeric signalling unit proposed by Javitch and Weinstein
(Han et al., 2009). Further, to satisfy all of the experimental restraints, the inter-
face of the CB2 homodimer had to be at TMH5-TMH6. This interface is similar
to that found for the chemokine CXCR4 receptor (Wu et al., 2010). Monomer
crosslinking studies were then undertaken to identify the homodimer interface
in CB2. Substituted cysteine experiments revealed that in the presence of HgCl2,
CB2 can dimerize at H6.57(267)C and at A6.60(270)C. These results are in
agreement with the dimer interface chosen above to satisfy all of the CB2/G-
protein crosslinks. [Support: RO1 DA003934 and KO5 DA021358 (PHR)].
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Structure-Function Studies of Detergent Solubilized PTH1R-GaSbg
Hilary P. Stevenson, Qiangm Zhang, Filippo Pullara, Guillermo Calero.
University of Pittsburgh, Pittsburgh, PA, USA.
G-protein coupled receptors (GPCRs) are seven-transmembrane signaling pro-
teins that bind and activate heterotrimeric G-proteins by facilitating the ex-
change of GDP for GTP. The structural and functional consequences of
GPCR-G protein binding have been well studied and include a high-resolution
structure of the agonist-GPCR-G-protein ternary complex. However, this
work has been performed almost entirely in Family A GPCRs, and have not in-
cluding the pharmacologically relevant peptide binding Family B GPCRs. The
Parathyroid Hormone Receptor Type 1 (PTH1R) is a prototypical Family B
member that couples with multiple G-proteins including GaSbg. The PTH1R
is a key regulator of extracellular calcium and phosphate homeostasis, and is
important in bone healing and regeneration. Structural studies of PTH1R and
its lipid modified cytosolic binding partner GaSbg have been limited by an in-
ability to obtain high yield purifications of either of these proteins. An additional
challenge is to obtain purifications conditions that provide detergent compatibil-
ity for PTH1R-GaSbg complex formation. In this study we have successfully
identified conditions for high yield purifications of both PTH1R and GaSbg.
Both proteins are 85 - 95% monodispersed in detergent conditions as measured
by Dynamic Light Scattering. Radio-ligand binding experiments demonstrate
that the proteins are functional. Furthermore, pull-down experiments show the
formation of the PTH1R-GaSbg complex. This complex is formed primarily
through interactions of PTH1R with the GaS subunit, with bg showing little
binding in the presence of agonist. Truncation mutants of the PTH1R were
also purified for use in identifying GaSbg essential binding sites. Taken
together, this system provides one of the first models for studying the direct
interaction of a Family BGPCRwith its cognateG protein. Structural studies us-
ing isolated proteins are being pursued for x-ray crystallographic study.
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Ligand Dynamics during Microsecond Simulations of the A2a Adenosine
Receptor
Ji Young Lee, Edward Lyman.
University of Delaware, Newark, DE, USA.
Thanks to their diversity of functions and widespread expression in all tis-
sues, activation of G-protein-coupled receptors (GPCRs) upon agonist bind-ing plays a critical role in cell signaling in many contexts. The GPCRs are
therefore one of the most important classes of protein as drug targets. Re-
cently, the crystal structure of the A2a adenosine receptor bound to agonist
adenosine (G. Lebon et al., Nature 474, 521 (2011)) or UK432097 (F. Xu
et al., Science 332, 322 (2011)) has been reported, offering insight into recep-
tor A2a ligand binding and activation. Using the crystal structures as a starting
point, we performed microsecond-timescale simulations of the A2a receptors
bound to adenosine or UK432097, as well as the antagonist ZM241385. Our
data suggest that adenosine is highly dynamic when bound to A2a, which
contrasts starkly with the larger ligands UK432097 and ZM241385. Analyz-
ing the simulation data in the context of published mutagensis experimental
data suggests that the extra molecular scaffold of the larger ligands serves to
stabilize key interactions, perhaps rationalizing the relative efficacy of differ-
ent agonists.
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Peptides Derived from the Transmembrane Domains of Toll-Like Recep-
tors (TLR) 2/6 Interfere with Hetero-Associate with the TLRs and Inhibit
their Activation
Yechiel Shai, Avner Fink, Christopher J. Arnusch, Liraz Shmuel-Galia,
Eliran Moshe Reuven, Niv Antonovsky.
The Weizmann Institute of Science, Rehovot, Israel.
Toll Like Receptors (TLRs) are major facilitators of the innate immune re-
sponse. Although the structure and function of TLRs are well studied, the
role of their transmembrane domain has not been fully understood. Here we
show that peptides based on the TM domain of TLR2 and TLR1/6 specifically
inhibit TLR2 activation. These peptides inhibited TNFa secretion by mouse
macrophages after lipotechoic acid (LTA, the cell wall of Gram-positive bac-
teria) activation, while no effect was seen on TLR4 activation by lipopolysa-
charide (LPS, the cell wall of Gram-negative bacteria). FRET analysis and
self assembly assays revealed that these TM peptides are capable of interacting
with each other, favoring hetero- rather than homo-dimerisation. Finally, a se-
lected TLR2 TM peptide was able to rescue up to 60% of mice affected by an
otherwise lethal acute systemic inflammation driven by hyperactivation of
TLR2.
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Structure Function Analysis of Innexin ShakingB(Lethal)
Adam D. DePriest, William D. Marks, Ingrid M. Skerrett.
Buffalo State College, Buffalo, NY, USA.
ShakingB(Lethal) is a gap junction protein that contributes to rectifying syn-
apses of the Drosophila Giant Fiber System. Like other innexins, ShakingB
(lethal) spans the membrane four times (M1-M4) with cytoplasmic amino
and carboxyl termini. Tryptophan-scanning analysis, recently applied to Sha-
kingB(Lethal) confirmed that the first transmembrane domain (M1) was he-
lical and identified four sites along one face of the helix that are likely to be
involved in helix-helix interactions (DePriest et al., in press). To further ex-
amine the nature and extent of interactions between transmembrane domains,
tryptophan-scanning mutagenesis was applied to the second transmembrane
domain (M2). Of the twelve sites tested so far, at least three were sensitive
to tryptophan substitution, identifying at least one helical face of M2 in-
volved in interactions between transmembrane domains. The structure and
function of the amino terminus of ShakingB(Lethal) was also addressed. De-
letion of the amino terminus induced complete disruption in gap junction
function. However, ShakingB(Lethal) was apparently unaffected by a variety
of amino acid substitutions within the amino terminus including tryptophan
substitution. A variety of truncations and substitutions are currently being
tested in order to identify regions of the amino terminus essential for
function.
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Comparison of Various Methods for Determining Functional Activity of
the Diphtheria Toxin T-Domain
Mykola V. Rodnin1, Alexander Kyrychenko1, Paul K. Kienker2,
Onkar Sharma3, Mauricio Vargas-Uribe1, R. John Collier3, Alan Finkelstein2,
Alexey S. Ladokhin1.
1KUMC, Kansas City, KS, USA, 2Albert Einstein College of Medicine,
Bronx, NY, USA, 3Harvard Medical School, Boston, MA, USA.
The function of diphtheria toxin translocation (T) domain is a transfer of cata-
lytic domain across endosomal membrane in response to acidification. The goal
of this study is to develop a simple and reliable in vitro functional assay for the
T-domain, one that can be used to investigate structure-function relationships
using interactions of various mutants with lipid bilayers of various composi-
tions. Traditionally the activity of the T-domain is estimated either by measur-
ing conductance in planar lipid bilayers or by measuring the release of
fluorescent markers from large unilamellar lipid vesicles. We have applied
